{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:12:00Z","timestamp":1789071120552,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016170","name":"Japan Blood Products Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K21331"],"award-info":[{"award-number":["25K21331"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejphar.2026.179248","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:38:21Z","timestamp":1786689501000},"page":"179248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Binding capacity of Intravenous immunoglobulin G to BK polyomavirus determines its anti-BK polyomavirus activity in infected cultures"],"prefix":"10.1016","volume":"1033","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7721-9359","authenticated-orcid":false,"given":"Noriaki","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-8082","authenticated-orcid":false,"given":"Atsuko","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4466-6504","authenticated-orcid":false,"given":"Masaya","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4389-1400","authenticated-orcid":false,"given":"Yoshinori","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-0397","authenticated-orcid":false,"given":"Kaoru","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1437-3177","authenticated-orcid":false,"given":"Shota","family":"Fukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-547X","authenticated-orcid":false,"given":"Kazunari","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2989-308X","authenticated-orcid":false,"given":"Seiya","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-9008","authenticated-orcid":false,"given":"Motoko","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5218-4249","authenticated-orcid":false,"given":"Kimiyasu","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejphar.2026.179248_bib1","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.ajt.2024.07.002","article-title":"Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1","volume":"24","author":"Abend","year":"2024","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179248_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/ndt\/gfaf002","article-title":"BK Polyomavirus-associated nephropathy - diagnostic and treatment standard","volume":"40","author":"Al-Talib","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179248_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/ajt.16233","article-title":"Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients-results from a proof-of-concept study","volume":"21","author":"Benotmane","year":"2021","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179248_bib4","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JVI.80.7.3495-3505.2006","article-title":"Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy","volume":"80","author":"Chen","year":"2006","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179248_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ekir.2022.12.020","article-title":"Incidence, risk factors, and outcomes of kidney transplant recipients with BK polyomavirus-associated nephropathy","volume":"8","author":"Gately","year":"2022","journal-title":"Kidney Int. Rep."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179248_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179248_bib7","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1097\/TP.0000000000004976","article-title":"The second international consensus guidelines on the management of BK polyomavirus in kidney transplantation","volume":"108","author":"Kotton","year":"2024","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179248_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011622","article-title":"Modelling BK polyomavirus dissemination and cytopathology using polarized human renal tubule epithelial cells","volume":"19","author":"Lorentzen","year":"2023","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179248_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.virol.2004.03.027","article-title":"BKV and SV40 infection of human kidney tubular epithelial cells in vitro","volume":"323","author":"Low","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.ejphar.2026.179248_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/TCRM.S273388","article-title":"Clinical efficacy of intravenous immunoglobulin for BK polyomavirus-associated nephropathy after living kidney transplantation","volume":"16","author":"Matsumura","year":"2020","journal-title":"Therapeut. Clin. Risk Manag."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179248_bib11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.virol.2007.09.030","article-title":"Intracellular trafficking pathway of BK virus in human renal proximal tubular epithelial cells","volume":"371","author":"Moriyama","year":"2008","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179248_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfad293","article-title":"Protocolized polyoma BK viral load monitoring and high-dose immunoglobulin treatment in children after kidney transplant","volume":"17","author":"Pollack","year":"2024","journal-title":"Clin. Kidney J."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179248_bib14","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/ajt.13083","article-title":"Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK","volume":"15","author":"Randhawa","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179248_bib13","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/TP.0b013e3181daaaf1","article-title":"Polyomavirus BK neutralizing activity in human immunoglobulin preparations","volume":"89","author":"Randhawa","year":"2010","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179248_bib15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ajt.2023.11.007","article-title":"Preemptive intravenous human immunoglobulin G suppresses BK polyomavirus replication and spread of infection in vitro","volume":"24","author":"Sato","year":"2024","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179248_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.transproceed.2015.01.012","article-title":"Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients","volume":"47","author":"Vu","year":"2015","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejphar.2026.179248_bib17","author":"Wang"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179248_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013122","article-title":"A highly potent human antibody neutralizing all serotypes of BK polyomavirus","volume":"21","author":"Weber","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2026.179248_bib19","author":"Wickham"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:04:51Z","timestamp":1789070691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926007302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"alternative-id":["S0014299926007302"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179248","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Binding capacity of Intravenous immunoglobulin G to BK polyomavirus determines its anti-BK polyomavirus activity in infected cultures","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179248"}}